4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-16-151281
Chief Financial Officer bought 900 shares at $5.50 ($4,950)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonner Michael Chief Financial Officer | 2016-11-17 | Purchase | +900 | $5.50 | $4,950 | 11,900 | D |
| Open-market purchases · 900 sh · avg $5.50 · $4,950 | |||||||
Loading xslF345X03/doc4.xml…